Track the 메지온 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 메지온 has recorded 32 insider filings. The latest transaction was filed on 30 June 2026 (Other). Among the most active insiders: 노성일. Every trade is accessible without an account.
32
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
3 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
메지온 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.